Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58,874,321
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
42,413,548
-
Shares change
-
-3,953,431
-
Total reported value, excl. options
-
$538,068,965
-
Value change
-
-$35,411,925
-
Put/Call ratio
-
51.64%
-
Number of buys
-
61
-
Number of sells
-
-51
-
Price
-
$12.69
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q2 2015
148 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q2 2015.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42,413,548 shares
of 58,874,321 outstanding shares and own 72.04% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT CO (4,784,157 shares), PAULSON & CO. INC. (3,946,500 shares), Palo Alto Investors, LLC (3,897,408 shares), GOLDMAN SACHS GROUP INC (2,836,486 shares), STATE STREET CORP (2,569,617 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (2,141,835 shares), BlackRock Fund Advisors (1,641,711 shares), MORGAN STANLEY (1,457,511 shares), venBio Select Advisor LLC (1,438,693 shares), and GREAT POINT PARTNERS LLC (1,413,599 shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.